Efficient Enantioselective Separation And Determination Of Trace Impurities In Secondary Amino Acids (i.e., Imino Acids)
Abstract
An R-(-)-1-(1-naphthyl)ethyl carbamoylated-β-cyclodextrin bonded phase in conjunction with a nonaqueous polar mobile phase was used for the highly selective enantioseparation of a number of secondary amino acids after their pre-column derivatization with 9-fluorenylmethyl chloroformate (FMOC). Under the conditions employed, the FMOC reagent served to "lock" the imino acid into their existing conformation thereby preventing the possibility of racemization. Furthermore, it served to increase the sensitivity to the point that trace level enantiomeric impurities were easily detected. Compared with separations that use traditional reversed-phase solvents, this method showed several advantages: higher selectivity towards the imino acid enantiomers investigated, shorter analysis times, faster equilibration of the column, more stable baseline and more sensitive fluorescence detection. The detection limits for FMOC derivatives of proline, trans-4-hydroxyproline, cis-4-hydroxyproline, pyroglutamic acid, 3,4-dehydroproline, thiaproline, penicillamine acetone adduct and pipecolic acid are in the low femtomole range. The method was used for evaluation of enantioselectivity of a number of "optically pure" commercial imino acid standards. Enantiomeric impurities as low as 0.0001% (1 ppm) can be determined in some cases. High precision determination of trace levels of d-imino acids in the presence of large amounts of corresponding (opposite) l enantiomer at 1, 0.1, 0.01% and below are demonstrated. © 1992.
Recommended Citation
J. Zukowski et al., "Efficient Enantioselective Separation And Determination Of Trace Impurities In Secondary Amino Acids (i.e., Imino Acids)," Journal of Chromatography A, vol. 623, no. 1, pp. 33 - 41, Elsevier, Oct 1992.
The definitive version is available at https://doi.org/10.1016/0021-9673(92)85295-5
Department(s)
Chemistry
International Standard Serial Number (ISSN)
0021-9673
Document Type
Article - Journal
Document Version
Citation
File Type
text
Language(s)
English
Rights
© 2023 Elsevier, All rights reserved.
Publication Date
09 Oct 1992
PubMed ID
1452629
Comments
National Institute of General Medical Sciences, Grant R01GM036292